logo

For the Inventor, By the Inventor

Warrenton, VA, United States of America

Microvax, LLC

Calculating rank
USPTO Granted Patents = 26

% Expired Patents = 73.1



Forward Citations = 32

Loading Chart...
Loading Chart...

5 inventors (with patents filed for the assignee):

goldMedal Albert B Deisseroth (26 out of 32 patents)

silverMedal Yucheng Tang (9 out of 9 patents)

bronzeMedal Wei-Wei Zhang (2 out of 2 patents)

4.  Xiang-Ming Fang (2 out of 2 patents)

5.  Nagy Habib (1 out of 18 patents)


Core Competencies:
SARS-CoV-2
Cancer Therapy
Dengue Vaccine
Tuberculosis
CD40 Ligand
Malaria
Ebola Virus
Immune Response
Mucin Antigen
Herpes Simplex
Burkholderia Pseudomallei

26 patents:

1. 12427191 - SARS-CoV-2 fusion protein vaccine/regimen (2025-09-30),
2. 11839655 - Combination cancer therapy (2023-12-12),
3. 11154603 - Burkholderia pseudomallei composition (2021-10-26),
4. 11097001 - Composition and method against tuberculosis (2021-08-24),
5. 11077183 - CD40 ligand fusion protein vaccine (2021-08-03),
6. 10835589 - Vaccine directed to induction of immune response to protein and glycolipid antigens of bacterial cells through interaction of CD40L/CD40 receptor axis with complex of glycolipid/CD1d receptor in NKT cells and in dendritic cells (2020-11-17),
7. 10426827 - Dengue hemorrhagic fever virus vaccine (2019-10-01),
8. 10383932 - Vaccine directed to induction of immune response to protein and glycolipid antigens of bacterial cells through interaction of CD4OL/CD40 receptor axis with complex of glycolipid/CD1d receptor in NKT cells and in dendritic cells (2019-08-20),
9. 10293040 - [object Object] (2019-05-21),
10. 10183067 - TAA/CD4OL composition/vaccine for malaria (2019-01-22),
11. 10174100 - [object Object] (2019-01-08),
12. 10166284 - Vaccines for herpes simplex virus 1 and 2 (2019-01-01),
13. 10149899 - Composition and method against C-difficile (2018-12-11),
14. 10130667 - TAA/ecdCD40L oncolytic virus (2018-11-20),
15. 10046041 - [object Object] (2018-08-14),
Company Overview
Microvax, LLC is a technology company based in Warrenton, Virginia, specializing in advanced solutions for the biotechnology and pharmaceutical sectors. The organization focuses on the development of innovative products and services that enhance the efficiency and effectiveness of vaccine production and delivery. With a commitment to research and development, Microvax aims to address critical challenges in public health through its cutting-edge technologies, contributing to the advancement of healthcare solutions on a global scale.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

26 Patents

#1 in Warrenton, VA

#220 in Virginia

#12,875 in US

#24,848 in the World

Warrenton, VA (US)
Warrenton, VA, United States of America

Microvax, LLC

Forward Citations = 32

5 inventors:

goldMedal Albert B Deisseroth (26 out of 32 patents)

silverMedal Yucheng Tang (9 out of 9 patents)

bronzeMedal Wei-Wei Zhang (2 out of 2 patents)

4.  Xiang-Ming Fang (2 out of 2 patents)

5.  Nagy Habib (1 out of 18 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Microvax, LLC. Retrieved from https://idiyas.com/company/microvax

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…